Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era.
Rheumatology (Oxford)
; 60(5): 2040-2045, 2021 05 14.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1048420
ABSTRACT
People with rheumatic and musculoskeletal diseases (RMDs) are facing several challenges during the COVID-19 pandemic, such as poor access to regular health services and drug shortages, particularly in developing countries. COVID-19 represents a syndemic, synergistic condition that interacts with and exacerbates pre-existing diseases such as RMDs, other co-morbidities and social conditions. The emerging evidence on both biological and non-biological factors implicated in worse outcomes in people with RMDs affected by the COVID-19 pandemic, whether infected by the virus or not, calls for the need to use more novel and holistic frameworks for studying disease. In this context, the use of a syndemic framework becomes particularly relevant. We appeal for a focus on the identification of barriers and facilitators to optimal care of RMDs in the context of the COVID-19 pandemic, in order to tackle both the pandemic itself and the health inequities inherent to it.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Enfermedades Reumáticas
/
Enfermedades Musculoesqueléticas
/
Sindémico
/
SARS-CoV-2
/
COVID-19
Tipo de estudio:
Estudio observacional
Límite:
Humanos
Idioma:
Inglés
Revista:
Rheumatology (Oxford)
Asunto de la revista:
Reumatología
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
Rheumatology
Similares
MEDLINE
...
LILACS
LIS